A possible explanation for the synergism might be enhanced phosphorylation levels of AKT due to palbociclib treatment, as, for example, observed in breast cancer, osteosarcoma, and glioblastoma cell lines [26,27,28,29]. The gene discussed is AKT1; the disease is osteosarcoma.